维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="Papagora"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Optimization of extracellular lipase production by Debaryomyces hansenii isolates from dry-salted olives using response surface methodology显示文摘	Papagora C Roukas T Kotzekidou P		0，，：	1
	2	Adult-onset Still's disease: clinical, serological and therapeutic considerations显示文摘	Iliou C Papagoras C Tsifetaki N	2012	Clin Exp Rheumatol2012，31，1：	1
	3	Cardiovascular risk profile in patients with spondyloarthritis 显示文摘	Papagoras C Markatseli TE Saougou I	2013	Joint Bone Spine2013，81，1：	1
	4	Atherosclerosis and cardiovascu- lar disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis 显示文摘	Papagoras C Voulgari PV Drosos AA	2013	Clin Exp Rheumato12013，31，4：	1
	5	Cardio- vascular risk prodile in patients with spondyloarthritis 显示文摘	Papagoras C Markatseli T E Saougou I	2014	Joint Bone Spine2014，81，：	1
	6	A case of Brucella spondylitis in a patient with psoriatic arthritis receiving infliximab 显示文摘	Papagoras CE Argyropoulou MI Voulgari PV	2009	Clinical and experimental rheumatology2009，27，1：	1
	7	Strategies after the failure of the flint anti-tumor necrosis factor alpha agent in rheumatoid arthritis 显示文摘	Papagoras C Voulgari PV Dmsos AA	2010	Autoimmun Rev2010，9，：	1
	8	Adalimumab in the treatment of rheumatoid arthritis显示文摘	Voulgari P V Kaltsonoudis E Papagoras C	2012	Expert Opin Biol Ther2012，12，12：	1
	9	Cardiovascular risk pro- file in patients with spondyloarthritis 显示文摘	Papagoras C Markatseli TE Saougou I	2013	Joint Bone Spine2013，81，1：	1
	10	Atherosclerosis and cardiovascu- lar disease in the spandyloaithritides, particularly ankylosing spondyli- tis and psoriatic arthritis显示文摘	Papagoras C Voulgari PV Drosos AA	2013	Clin Exp Rheumatol2013，31，4：	1
	11	Adult-onset Still's disease: clinical, serological and therapeutic considerations 显示文摘	Iliou C Papagoras C Tsifetaki N	2012	Clin Exp Rheumatol2012，，：	1
	12	Adalimumab in the treatment of rheumatoid arthritis 显示文摘	VOULGARI P V KALTSONOUDIS E PAPAGORAS C	2012	Exp Opin Biol Ther2012，12，12：	1
	13	Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation显示文摘AIM: To investigate the use of Daclizumab (Dmab) as an immunosuppressive agent in an experimental model of hepatocyte xenotransplantation (XenoTx) in rats with fulminant hepatic failure (FHF). METHODS: Two white male New Zealand rabbits were used as donors and 68 Wistar rats as recipients. FHF was induced by intravenous application of dimethylnitrosamine (DMNA). The isolated hepatocytes of the rabbits were xenotransplanted into the spleen of the rats 24 h after FHF induction. Group A (n = 13): no treatment; Group B (n = 14): FHF and XenoTx; Group C (n = 14): FHF and XenoTx and cyclosporin (CsA); Group D (n = 14): FHF and XenoTx and Dmab; Group E (n = 13): FHF and XenoTx and CsA and Dmab. The rats were followed for 15 d. RESULTS: Statistical analysis showed better survival among groups D (92.86%) and E (76.92%) compared to group A (all rats died after 72 h), group B (28.57%) or group C (71.43%), although the differences were not statistically significant. Biochemical evaluation of the liver enzymes and histology confirmed satisfactory function and engraftment, respectively. CONCLUSION: This experimental model has shown the safe, effective and beneficial use of Dmab in a xenotransplantation model of rabbit hepatocytes in rats.	Dimitrios Papagoras Apostolos Papalois Alexandra Tsaroucha Dimitrios Lytras John Kyriazanos Nikoletta Giannakou Prodromos Laftsidis Constantine Simopoulos	2007	World Journal of Gastroenterology2007，13，9：	0
	14	Framing the preoperative assessment of the oncogreriatric patient. The surgeon’s point of view显示文摘Elderly cancer patients represent a steadily rising population constituting a daily problem for any physician, who is confronted not only with medical questions but also with ethical and social dilemmas. In addition oncogeriatric patients are underrepresented or excluded from trials especially in surgery which results in a gap in practical and evidence based knowledge regarding their preoperative evaluation and treatment. Therefore the authors outline the framework a decision making process for a meaning – and success- full treatment plan has to rely on.	Dimitris Papagoras Maria Kanara Stella Ntouvli	2018	Advanced Emergency Medicine2018，7，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费